{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:33:11Z","timestamp":1791271991562,"version":"4.1.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T00:00:00Z","timestamp":1357603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Phosphorylation of the RelA subunit at serine 536 (RelA-P-Ser536) is important for hepatic myofibroblast survival and is mechanistically implicated in liver fibrosis. Here, we show that a cell-permeable competing peptide (P6) functions as a specific targeted inhibitor of RelA-P-Ser536<\/jats:bold>\n                                 <jats:bold>\n                                    in vivo\n                                 <\/jats:bold>\n                                 <jats:bold>and exerts an antifibrogenic effect in two progressive liver disease models, but does not impair hepatic inflammation or innate immune responses after lipopolysaccharide challenge. Using kinase assays and western blotting, we confirm that P6 is a substrate for the inhibitory kappa B kinases (IKKs), IKK\u03b1 and IKK\u03b2, and, in human hepatic myofibroblasts, P6 prevents RelA-P-Ser536, but does not affect IKK activation of I\u03baB\u03b1. We demonstrate that RelA-P-Ser536 is a feature of human lung and skin fibroblasts, but not lung epithelial cells,<\/jats:bold>\n                                 <jats:bold>\n                                    in vitro\n                                 <\/jats:bold>\n                                 <jats:bold>and is present in sclerotic skin and diseased lungs of patients suffering from idiopathic pulmonary fibrosis.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>\n                                 <jats:bold>RelA-P-Ser536 may be a core fibrogenic regulator of fibroblast phenotype.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26068","type":"journal-article","created":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T16:37:41Z","timestamp":1348072661000},"page":"817-828","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":43,"title":["Inhibition of RelA-Ser536 Phosphorylation by a Competing Peptide Reduces Mouse Liver Fibrosis Without Blocking the Innate Immune Response"],"prefix":"10.1097","volume":"57","author":[{"given":"Anna","family":"Moles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay B.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saimir","family":"Luli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Borthwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M.","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil D.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair D.","family":"Burt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek A.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Oakley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-40-20241201","doi-asserted-by":"crossref","first-page":"16551669","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis.","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"R2-40-20241201","doi-asserted-by":"crossref","first-page":"481497","DOI":"10.1016\/j.cld.2006.08.022","article-title":"Reversal of fibrosis: no longer a pipe dream?","volume":"10","author":"Fallowfield","year":"2006","journal-title":"Clin Liver Dis"},{"key":"R3-40-20241201","doi-asserted-by":"crossref","first-page":"538549","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.","volume":"102","author":"Iredale","year":"1998","journal-title":"J Clin Invest"},{"key":"RU4-40-20241201","doi-asserted-by":"crossref","first-page":"927939","DOI":"10.1007\/s10495-005-1055-4","article-title":"The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis.","volume":"10","author":"Elsharkawy","year":"2005","journal-title":"Apoptosis"},{"key":"R5-40-20241201","doi-asserted-by":"crossref","first-page":"203234","DOI":"10.1101\/gad.183434.111","article-title":"NFkappaB, the first quartercentury: remarkable progress and outstanding questions.","volume":"26","author":"Hayden","year":"2012","journal-title":"Genes Dev"},{"key":"RU6-40-20241201","first-page":"725734","article-title":"NFkappaB regulation in the immune system.","volume":"2","author":"Li","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R7-40-20241201","doi-asserted-by":"crossref","first-page":"695708","DOI":"10.1016\/S0002-9440(10)62291-2","article-title":"Nuclear factorkappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury.","volume":"166","author":"Oakley","year":"2005","journal-title":"Am J Pathol"},{"key":"R8-40-20241201","doi-asserted-by":"crossref","first-page":"922931","DOI":"10.1002\/hep.23385","article-title":"The cRel subunit of nuclear factorkappaB regulates murine liver inflammation, woundhealing, and hepatocyte proliferation.","volume":"51","author":"Gieling","year":"2010","journal-title":"HEPATOLOGY"},{"key":"RU10-40-20241201","doi-asserted-by":"crossref","first-page":"589597","DOI":"10.1016\/j.jhep.2007.12.019","article-title":"NFkappaB is a critical regulator of the survival of rodent and human hepatic myofibroblasts.","volume":"48","author":"Watson","year":"2008","journal-title":"J Hepatol"},{"key":"R11-40-20241201","doi-asserted-by":"crossref","first-page":"144150","DOI":"10.1038\/ni.1976","article-title":"IL1betadriven neutrophilia preserves antibacterial defense in the absence of the kinase IKKbeta.","volume":"12","author":"Hsu","year":"2011","journal-title":"Nat Immunol"},{"key":"RU12-40-20241201","doi-asserted-by":"crossref","first-page":"977990","DOI":"10.1016\/j.cell.2005.04.014","article-title":"IKKbeta couples hepatocyte death to cytokinedriven compensatory proliferation that promotes chemical hepatocarcinogenesis.","volume":"121","author":"Maeda","year":"2005","journal-title":"Cell"},{"key":"R13-40-20241201","doi-asserted-by":"crossref","first-page":"275285","DOI":"10.1038\/sj.cdd.4401979","article-title":"Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis.","volume":"14","author":"Mann","year":"2007","journal-title":"Cell Death Differ"},{"key":"R14-40-20241201","doi-asserted-by":"crossref","first-page":"67176730","DOI":"10.1038\/sj.onc.1209937","article-title":"Posttranslational modifications regulating the activity and function of the nuclear factor kappa B pathway.","volume":"25","author":"Perkins","year":"2006","journal-title":"Oncogene"},{"key":"R15-40-20241201","doi-asserted-by":"crossref","first-page":"10871089","DOI":"10.1042\/BST0321087","article-title":"Posttranslational modification of RelA(p65) NFkappaB.","volume":"32","author":"Campbell","year":"2004","journal-title":"Biochem Soc Trans"},{"key":"R16-40-20241201","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/01.RES.0000244015.10655.3f","article-title":"RhoA mediates angiotensin IIinduced phosphoSer536 nuclear factor kappaBRelA subunit exchange on the interleukin6 promoter in VSMCs.","volume":"99","author":"Cui","year":"2006","journal-title":"Circ Res"},{"key":"R17-40-20241201","doi-asserted-by":"crossref","first-page":"36916","DOI":"10.1074\/jbc.M301598200","article-title":"Tumor necrosis factoralphainduced IKK phosphorylation of NFkappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway.","volume":"278","author":"Sakurai","year":"2003","journal-title":"J Biol Chem"},{"key":"R18-40-20241201","doi-asserted-by":"crossref","first-page":"3453834547","DOI":"10.1074\/jbc.M504943200","article-title":"Phosphorylation of RelAp65 on serine 536 defines an IkappaBalphaindependent NFkappaB pathway.","volume":"280","author":"Sasaki","year":"2005","journal-title":"J Biol Chem"},{"key":"R19-40-20241201","doi-asserted-by":"crossref","first-page":"19071916","DOI":"10.2337\/db10-1262","article-title":"Klotho depletion contributes to increased inflammation in kidney of the dbdb mouse model of diabetes via RelA (serine)536 phosphorylation.","volume":"60","author":"Zhao","year":"2011","journal-title":"Diabetes"},{"key":"R20-40-20241201","doi-asserted-by":"crossref","first-page":"2697626984","DOI":"10.1074\/jbc.M603133200","article-title":"IKKiIKKepsilon controls constitutive, cancer cellassociated NFkappaB activity via regulation of Ser536 p65RelA phosphorylation.","volume":"281","author":"Adli","year":"2006","journal-title":"J Biol Chem"},{"key":"R21-40-20241201","doi-asserted-by":"crossref","first-page":"1509615104","DOI":"10.1074\/jbc.M311192200","article-title":"Identification of a p65 peptide that selectively inhibits NFkappa B activation induced by various inflammatory stimuli and its role in downregulation of NFkappaBmediated gene expression and upregulation of apoptosis.","volume":"279","author":"Takada","year":"2004","journal-title":"J Biol Chem"},{"key":"R22-40-20241201","doi-asserted-by":"crossref","first-page":"590597","DOI":"10.1002\/hep.21802","article-title":"Nuclear factorkappaB and the hepatic inflammationfibrosiscancer axis.","volume":"46","author":"Elsharkawy","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R23-40-20241201","doi-asserted-by":"crossref","first-page":"285291","DOI":"10.1016\/j.jhep.2009.10.030","article-title":"NFkappaB signalling: embracing complexity to achieve translation.","volume":"52","author":"Chakraborty","year":"2010","journal-title":"J Hepatol"},{"key":"R24-40-20241201","doi-asserted-by":"crossref","first-page":"121132","DOI":"10.1038\/nrc3204","article-title":"The diverse and complex roles of NFkappaB subunits in cancer.","volume":"12","author":"Perkins","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"R25-40-20241201","doi-asserted-by":"crossref","first-page":"56305635","DOI":"10.4049\/jimmunol.170.11.5630","article-title":"IKK beta plays an essential role in the phosphorylation of RelAp65 on serine 536 induced by lipopolysaccharide.","volume":"170","author":"Yang","year":"2003","journal-title":"J Immunol"},{"key":"R26-40-20241201","doi-asserted-by":"crossref","first-page":"11381143","DOI":"10.1038\/nature03491","article-title":"IKKalpha limits macrophage NFkappaB activation and contributes to the resolution of inflammation.","volume":"434","author":"Lawrence","year":"2005","journal-title":"Nature"},{"key":"R27-40-20241201","doi-asserted-by":"crossref","first-page":"1327513284","DOI":"10.1074\/jbc.M512815200","article-title":"The proinflammatory actions of angiotensin II are dependent on p65 phosphorylation by the IkappaB kinase complex.","volume":"281","author":"Douillette","year":"2006","journal-title":"J Biol Chem"},{"key":"R28-40-20241201","doi-asserted-by":"crossref","first-page":"18301841","DOI":"10.1038\/cdd.2010.47","article-title":"Novel antiapoptotic mechanism of A20 through targeting ASK1 to suppress TNFinduced JNK activation.","volume":"17","author":"Won","year":"2010","journal-title":"Cell Death Differ"},{"key":"R29-40-20241201","doi-asserted-by":"crossref","first-page":"242246","DOI":"10.1126\/science.1164860","article-title":"Pulsatile stimulation determines timing and specificity of NFkappaBdependent transcription.","volume":"324","author":"Ashall","year":"2009","journal-title":"Science"},{"key":"R30-40-20241201","doi-asserted-by":"crossref","first-page":"552553","DOI":"10.1038\/nm0511-552","article-title":"Scraping fibrosis: expressway to the core of fibrosis.","volume":"17","author":"Mehal","year":"2011","journal-title":"Nat Med"},{"key":"R31-40-20241201","doi-asserted-by":"crossref","first-page":"e4393","DOI":"10.1371\/journal.pone.0004393","article-title":"Ser276 phosphorylation of NFkB p65 by MSK1 controls SCF expression in inflammation.","volume":"4","author":"Reber","year":"2009","journal-title":"PLoS One"},{"key":"R32-40-20241201","doi-asserted-by":"crossref","first-page":"17581760","DOI":"10.1096\/fj.05-3736fje","article-title":"IKKbeta phosphorylates p65 at S468 in transactivaton domain 2.","volume":"19","author":"Schwabe","year":"2005","journal-title":"FASEB J"},{"key":"RU33-40-20241201","doi-asserted-by":"crossref","first-page":"36233638","DOI":"10.1128\/MCB.01152-07","article-title":"RelA Ser276 phosphorylation is required for activation of a subset of NFkappaBdependent genes by recruiting cyclindependent kinase 9cyclin T1 complexes.","volume":"28","author":"Nowak","year":"2008","journal-title":"Mol Cell Biol"},{"key":"RU34-40-20241201","doi-asserted-by":"crossref","first-page":"61756183","DOI":"10.1074\/jbc.M508045200","article-title":"Inducible phosphorylation of NFkappa B p65 at serine 468 by T cell costimulation is mediated by IKK epsilon.","volume":"281","author":"Mattioli","year":"2006","journal-title":"J Biol Chem"},{"key":"R35-40-20241201","doi-asserted-by":"crossref","first-page":"30323040","DOI":"10.1091\/mbc.e11-04-0280","article-title":"The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migration.","volume":"22","author":"Msaki","year":"2011","journal-title":"Mol Biol Cell"},{"key":"RU36-40-20241201","doi-asserted-by":"crossref","first-page":"4957149574","DOI":"10.1074\/jbc.C400442200","article-title":"Phosphorylation of serine 468 by GSK3beta negatively regulates basal p65 NFkappaB activity.","volume":"279","author":"Buss","year":"2004","journal-title":"J Biol Chem"},{"key":"R37-40-20241201","doi-asserted-by":"crossref","first-page":"H2103H2111","DOI":"10.1152\/ajpheart.00393.2005","article-title":"InhibitorkappaB kinasebeta regulates LPSinduced TNFalpha production in cardiac myocytes through modulation of NFkappaB p65 subunit phosphorylation.","volume":"289","author":"Hall","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R38-40-20241201","doi-asserted-by":"crossref","first-page":"5563355643","DOI":"10.1074\/jbc.M409825200","article-title":"Constitutive and interleukin1inducible phosphorylation of p65 NFkappaB at serine 536 is mediated by multiple protein kinases including IkappaB kinase (IKK)alpha, IKKbeta, IKKepsilon, TRAF family memberassociated (TANK)binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATAbinding proteinassociated factor II31mediated interleukin8 transcription.","volume":"279","author":"Buss","year":"2004","journal-title":"J Biol Chem"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26068","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.26068","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.26068","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201302000-00040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:07:12Z","timestamp":1733062032000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201302000-00040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26068","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}